HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019.
Shinnosuke YanagisawaYoichi OikawaSotaro TakagiYuta HorikoshiAtsushi SatomuraKazuo ImaiJun SakaiNoriomi IshibashiNorihito TarumotoShinichiro IidaHideto NakayamaYoshiyuki HagaShigefumi MaesakiAkira ShimadaPublished in: Journal of diabetes investigation (2022)
In addition to male sex, age, and serum CRP levels, HbA1c levels on admission may serve as a risk factor for oxygen therapy requirement during the clinical course of COVID-19, irrespective of diabetes history and status. This may contribute to the efficient delegation of limited numbers of hospital beds to patients at risk for oxygen therapy requirement.
Keyphrases
- coronavirus disease
- end stage renal disease
- type diabetes
- emergency department
- healthcare
- ejection fraction
- newly diagnosed
- cardiovascular disease
- sars cov
- chronic kidney disease
- stem cells
- metabolic syndrome
- adipose tissue
- mesenchymal stem cells
- patient reported outcomes
- insulin resistance
- smoking cessation
- replacement therapy